Dr. Alexander Fleming is Founder and Executive Chairman of Kinexum, a company of professionals from across the world with diverse expertise in developing drugs, biotech products, medical devices and digital health technologies. He is also Executive Vice-President of Tolerion, a biotechnology company developing disease-modifying treatments for type 1 diabetes and other autoimmune diseases. Dr. Fleming [...]

Dr. Michael Zemel is founder and CSO of NuSirt Biopharma, where he leads research programs focused on energy-sensing and development of therapeutics for diseases of aging and over-nutrition. Previously, he was Professor of Nutrition and of Medicine at the University of Tennessee from 1990-2012, where his work focused on energy sensing, muscle-fat cross-talk, and regulation [...]

Dr. Alan C. Moses served for nearly five years as the Chief Medical Officer and Senior Vice President of the Joslin Diabetes Center, specifically responsible for the operation of the Joslin Clinic. In 2004, Dr. Moses joined Novo Nordisk, Inc and retired in 2018 in the role of Global Chief Medical Officer. He was deeply [...]